From a judge denying the FTC's attempt to block a two-hospital deal in North Carolina to two former high-ranking employees filing a False Claims Act complaint against Erlanger Health System, here are 12 lawsuits, settlements and legal developments Becker's has…
Legal & Regulatory Issues
Los Angeles-based Prospect Medical Holdings is suing Yale New Haven Health, demanding that the Connecticut health system honor its contractual obligations to acquire Eastern Connecticut Health Network and Waterbury Hospital.
A majority panel for the U.S. Court of Appeals for the Ninth Circuit has reversed a 2022 jury verdict in favor of Sacramento, Calif.-based Sutter Health in a class action alleging the health system used its market power to charge…
A federal judge has rejected the Federal Trade Commission's request for a preliminary injunction to bar Winston-Salem, N.C.-based Novant Health from its $320 million acquisition of two North Carolina hospitals from Franklin, Tenn.-based Community Health Systems.
Portland, Ore.-based Legacy Health will pay an undisclosed amount to settle a lawsuit with parents of a burn victim from an apartment fire, The Oregonian reported June 4.
Advertisement
From a Massachussettes hospital settling allegations it knowingly billed for procedures that didn't follow Medicare rules to the conviction of a Texas physician in a $70 million scheme, here are 10 healthcare billing fraud cases Becker's has reported since May…
The manufacturer of Ozempic and Wegovy filed nine additional lawsuits against businesses in six states that allegedly sold unapproved compounded versions of the popular drugs.
The former CEO of Williamson (W.Va.) Memorial Hospital has admitted stealing hospital funds for personal use and without authorization, according to the Justice Department.
Doctors Medical Center in Modesto, Calif., has been cited for immediate jeopardy by CMS, the California Department of Public Health confirmed to Becker's May 30.
A national trade group representing laboratories filed a lawsuit against the FDA on May 29, arguing the agency's recent final rule to treat laboratory-developed tests as medical devices exceeds its statutory authority.